Rapport Therapeutics, Inc. Common Stock
RAPP
NASDAQ·Healthcare·Biotechnology·Mkt cap $2.2B
$45.77
▼ -3.95%
P/E
-15.06
Mkt Cap
$2.2B
52-Wk Range
$22.06–$52.93
52-Week Range
$22.06 - $52.93
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 45.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Picomolar affinity AMPAR inhibition with TARPy8 selectivity for improved efficacy and safety
- Differentiated chemical and pharmacokinetic properties across pipeline candidates
- Experienced management team from Precision Neuroscience with deep CNS drug development expertise
- Multiple clinical programs addressing large market opportunities with high unmet medical needs
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Clinical trial progression of RAP-219 in focal epilepsy and expansion into additional CNS indications
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Hot
+24.8% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying RAPP right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 5, 2026
Reported EPS of -$1.19 vs -$1.12 consensus (-6.3% surprise).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-6.3%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$20.0M
$0
Margins · last 8Q
Profit
—
Wall Street consensus
6 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Raymond James · Aug 17, 2026
vs Industry
How RAPP stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related